U.S. markets close in 2 hours 14 minutes
  • S&P 500

    4,396.82
    -4.64 (-0.11%)
     
  • Dow 30

    34,936.48
    -122.04 (-0.35%)
     
  • Nasdaq

    14,725.13
    +64.55 (+0.44%)
     
  • Russell 2000

    2,214.51
    +22.68 (+1.03%)
     
  • Crude Oil

    72.39
    +0.74 (+1.03%)
     
  • Gold

    1,798.50
    -1.30 (-0.07%)
     
  • Silver

    24.83
    +0.18 (+0.73%)
     
  • EUR/USD

    1.1816
    -0.0010 (-0.08%)
     
  • 10-Yr Bond

    1.2560
    +0.0220 (+1.78%)
     
  • GBP/USD

    1.3878
    -0.0001 (-0.00%)
     
  • USD/JPY

    110.0780
    +0.3110 (+0.28%)
     
  • BTC-USD

    39,215.45
    +1,353.40 (+3.57%)
     
  • CMC Crypto 200

    921.65
    -8.28 (-0.89%)
     
  • FTSE 100

    7,016.63
    +20.55 (+0.29%)
     
  • Nikkei 225

    27,581.66
    -388.56 (-1.39%)
     

Natus Medical (NTUS) Surges 6.6%: Is This an Indication of Further Gains?

·2 min read

Natus Medical NTUS shares rallied 6.6% in the last trading session to close at $28.25. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 10.7% gain over the past four weeks.

Natus Medical recorded a strong price rise on investors’ optimism surrounding its impending first-quarter 2021 earnings result. The Zacks Consensus Estimate for the first-quarter earnings is pegged at 16 cents, an expected 300% surge from the year-ago reported figure.

Price and Consensus

Price Consensus Chart for NTUS
Price Consensus Chart for NTUS

This maker of medical device for newborn care is expected to post quarterly earnings of $0.16 per share in its upcoming report, which represents a year-over-year change of +300%. Revenues are expected to be $111.4 million, up 1.9% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For Natus Medical, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on NTUS going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank 1 (Strong Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Natus Medical Incorporated (NTUS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research